Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.384
Neutral
RSI(14)
56.932
Neutral
STOCH(KDJ)(9,3,3)
51.093
Neutral
ATR(14)
5.297
Low Volatility
CCI(14)
46.665
Neutral
Williams %R
47.953
Neutral
TRIX(12,20)
0.587
Sell
StochRSI(14)
100.000
Buy
Albemarle Corp
ALB98.230USD
+0.340+0.35%
Close 10/31, 16:00（ET）Quotes delayed by 15 min
11.56BMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Albemarle Corp
Currency: USD Updated: 2025-10-31Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Albemarle Corp's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
27
analysts
Hold
Current Rating
96.365
Target Price
-1.56%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Albemarle Corp Highlights
StrengthsRisks
Albemarle Corporation is engaged in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The Company’s segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its Ketjen segment includes clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS). It serves various markets such as grid storage, automotive, aerospace, conventional energy, and others.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PB is 1.44, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 116.94M shares, decreasing 6.76% quarter-over-quarter.
Held by PRIMECAP Management
Star Investor PRIMECAP Management holds 3.31M shares of this stock.
Financial Health
Currency: USD Updated: 2025-10-31The company's current financial score is 6.84, which is lower than the Chemicals industry's average of 7.35. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 1.33B, representing a year-over-year decrease of 7.02%, while its net profit experienced a year-over-year decrease of 91.83%.
Score
Financials
9.43
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
6.59
Operational Efficiency
6.60
Growth Potential
6.03
Shareholder Returns
5.55
Albemarle Corp's Company Valuation
Currency: USD Updated: 2025-10-31The company’s current valuation score is 7.78, which is higher than the Chemicals industry's average of 7.47. Its current P/E ratio is -10.53, which is -564.50% below the recent high of 48.92 and -101.12% above the recent low of -21.18.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 30/70
No Data
Earnings Forecast
Currency: USD Updated: 2025-10-31The company’s current earnings forecast score is 6.67, which is lower than the Chemicals industry's average of 7.26. The average price target for Albemarle Corp is 90.00, with a high of 168.11 and a low of 58.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
27
analysts
Hold
Current Rating
96.365
Target Price
-1.56%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
22
Total
5
Median
7
Average
Company name
Ratings
Analysts
Albemarle Corp
ALB
27
Ecolab Inc
ECL
27
Eastman Chemical Co
EMN
19
Celanese Corp
CE
18
Sociedad Quimica y Minera de Chile SA
SQM
14
Element Solutions Inc
ESI
12
1
2
3
4
5
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-10-31The company’s current price momentum score is 6.70, which is higher than the Chemicals industry's average of 6.68. Sideways: Currently, the stock price is trading between the resistance level at 107.29 and the support level at 88.83, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
97.366
Buy
MA10
96.858
Buy
MA20
95.398
Buy
MA50
87.144
Buy
MA100
78.994
Buy
MA200
74.235
Buy
Institutional Confidence
Currency: USD Updated: 2025-10-31The company’s current institutional recognition score is 10.00, which is higher than the Chemicals industry's average of 6.91. The latest institutional shareholding proportion is 99.37%, representing a quarter-over-quarter decrease of 0.84%. The largest institutional shareholder is The Vanguard, holding a total of 14.70M shares, representing 12.49% of shares outstanding, with 0.96% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
Capital World Investors
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
Franklin Advisers, Inc.
Capital Research Global Investors
Geode Capital Management, L.L.C.
ProShare Advisors LLC
1
2
Risk Assessment
Currency: USD Updated: 2025-10-31The company’s current risk assessment score is 5.17, which is lower than the Chemicals industry's average of 5.83. The company's beta value is 1.71. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.71
VaR
+5.30%
240-Day Maximum Drawdown
+54.39%
240-Day Volatility
+60.03%
Return
Best Daily Return
60 days
+8.50%
120 days
+8.50%
5 years
+19.13%
Worst Daily Return
60 days
-11.49%
120 days
-11.49%
5 years
-19.91%
Sharpe Ratio
60 days
+2.75
120 days
+2.10
5 years
+0.06
Risk Assessment
Maximum Drawdown
240 days
+54.39%
3 years
+82.51%
5 years
+84.40%
Return-to-Drawdown Ratio
240 days
-0.07
3 years
-0.24
5 years
-0.10
Skewness
240 days
+0.09
3 years
-0.00
5 years
-0.17
Volatility
Realised Volatility
240 days
+60.03%
5 years
+52.53%
Standardised True Range
240 days
+4.00%
5 years
+7.54%
Downside Risk-Adjusted Return
120 days
+310.25%
240 days
+310.25%
Maximum Daily Upside Volatility
60 days
+59.95%
Maximum Daily Downside Volatility
60 days
+51.88%
Liquidity
Average Turnover Rate
60 days
+3.68%
120 days
+3.30%
5 years
--
Turnover Deviation
20 days
+31.01%
60 days
+38.08%
120 days
+23.89%
Peer Comparison
Chemicals
Albemarle Corp
ALB
7.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Koppers Holdings Inc
KOP
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cabot Corp
CBT
8.16 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Balchem Corp
BCPC
8.12 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Element Solutions Inc
ESI
8.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CF Industries Holdings Inc
CF
7.96 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
